Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Baxter International    BAX

BAXTER INTERNATIONAL (BAX)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
02/16/2018 02/20/2018 02/21/2018 02/22/2018 02/23/2018 Date
66.33(c) 67.04(c) 67.05(c) 67.43(c) 68.36(c) Last
3 732 229 3 784 188 2 517 128 4 542 103 2 059 718 Volume
-0.17% +1.07% +0.01% +0.57% +1.38% Change
More quotes
Financials ($)
Sales 2018 11 242 M
EBIT 2018 1 910 M
Net income 2018 1 437 M
Finance 2018 664 M
Yield 2018 1,02%
Sales 2019 11 782 M
EBIT 2019 2 175 M
Net income 2019 1 647 M
Finance 2019 1 503 M
Yield 2019 1,20%
P/E ratio 2018 26,73
P/E ratio 2019 22,79
EV / Sales2018 3,19x
EV / Sales2019 2,97x
Capitalization 36 531 M
More Financials
Company
Baxter International, Inc. provides a broad portfolio of essential renal and hospital products, including acute and chronic dialysis; sterile IV solutions; infusion systems and devices; parenteral nutrition therapies; premixed and oncolytic injectables; biosurgery products and anesthetics; drug... 
More about the company
Surperformance© ratings of Baxter International
Trading Rating : Investor Rating :
More Ratings
Latest news on BAXTER INTERNATIONAL
02/23BAXTER INTERNATIONAL INC : Change in Directors or Principal Officers (form 8-K)
AQ
02/23BAXTER INTERNATIONAL : to Present at the Barclays Global Healthcare Conference
AQ
02/23BAXTER INTERNATIONAL : Management's Discussion and Analysis of Financial Conditi..
AQ
02/22BAXTER INTERNATIONAL : Hospitals Grapple with National IV Bag Shortage
AQ
02/20BAXTER INTERNATIONAL : Declares Quarterly Dividend and Announces Expanded Share ..
BU
02/15BAXTER INTERNATIONAL : U.S. Patents Awarded to Inventors in Florida (Feb. 15)
AQ
02/15BAXTER INTERNATIONAL : to Present at the Raymond James & Associates 39th Annual ..
AQ
02/12BAXTER INTERNATIONAL : New Drug Delivery Technologies Extending to Even Aspirin
AQ
02/08BAXTER INTERNATIONAL : Klingenstein Fields & Co. LLC Sells 1,370 Shares of Baxte..
AQ
02/07BAXTER INTERNATIONAL : Reports 2017 Fourth-Quarter and Full-Year Results
AQ
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
02/23Legal hurdles, not Amazon, key concern for U.S. dental supply firms
RE
02/21OMAR ISHRAK : Pay if It Works -- WSJ
DJ
02/20MEDTRONIC : U.S. Revenue Drops -- Earnings Review
DJ
02/20MEDTRONIC MOVES TO A NEW HEALTH-CARE : Pay Only if It Works
DJ
02/15STRYKER : U.S. Regulators Extend Window for Critical Stroke Treatment
DJ
More sector news : Medical Equipment, Supplies & Distribution - NEC
Latest Tweets
02/23$BAX ALERT: New Baxter International Inc. SEC Filing From our Stock News Aler.. 
02/21Norinchukin Bank The Raises Position in Baxter International Inc $BAX  
02/20Baxter Declares Quarterly Dividend and Announces Expanded Share Repurchase Au.. 
02/20Baxter International : Declares Quarterly Dividend and Announces Expanded Sha.. 
02/20$BAX Baxter Declares Quarterly Dividend and Announces Expanded Share Repurcha.. 
More tweets
Qtime:118
News from SeekingAlpha
02/22Tracking Dan Loeb's Third Point Portfolio - Q4 2017 Update 
02/21Tracking Tweedy Browne Portfolio - Q4 2017 Update 
02/20Baxter declares $0.16 dividend 
02/20Premarket analyst action - healthcare 
02/09Merger Arbitrage Opportunity In NxStage Medical - $30 Cash Offer From Freseni.. 
Chart BAXTER INTERNATIONAL
Duration : Period :
Baxter International Technical Analysis Chart | BAX | US0718131099 | 4-Traders
Technical analysis trends BAXTER INTERNATIONAL
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Average target price 75,6 $
Spread / Average Target 13%
EPS Revisions
Managers
NameTitle
José E. Almeida Chairman, President & Chief Executive Officer
Scott Pleau Vice President-Operations
James K. Saccaro Chief Financial Officer & Vice President
Paul E. Martin Chief Information Officer & Vice President
John D. Forsyth Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
BAXTER INTERNATIONAL4.32%36 531
MEDTRONIC PLC-0.42%109 254
ZIMMER BIOMET HOLDINGS-2.56%24 030
ALIGN TECHNOLOGY16.87%20 216
HOYA CORPORATION-6.17%19 502
TERUMO CORP1.67%19 406